0001593968-19-001274.txt : 20190604
0001593968-19-001274.hdr.sgml : 20190604
20190604125800
ACCESSION NUMBER: 0001593968-19-001274
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20190601
FILED AS OF DATE: 20190604
DATE AS OF CHANGE: 20190604
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Niederhuber John
CENTRAL INDEX KEY: 0001501240
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37746
FILM NUMBER: 19875882
MAIL ADDRESS:
STREET 1: 2273 RESEARCH BLVD. SUITE 400
CITY: ROCKVILLE
STATE: MD
ZIP: 20850
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Aptevo Therapeutics Inc.
CENTRAL INDEX KEY: 0001671584
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 811567056
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 2401 4TH AVE.
STREET 2: SUITE 1050
CITY: SEATTLE
STATE: WA
ZIP: 98121
BUSINESS PHONE: 206-838-0500
MAIL ADDRESS:
STREET 1: 2401 4TH AVE.
STREET 2: SUITE 1050
CITY: SEATTLE
STATE: WA
ZIP: 98121
4
1
primary_01.xml
PRIMARY DOCUMENT
X0306
4
2019-06-01
0001671584
Aptevo Therapeutics Inc.
APVO
0001501240
Niederhuber John
2401 4TH AVENUE
SUITE 1050
SEATTLE
WA
98121
true
false
false
false
Board of Directors
Option (right to buy)
0.7250
2019-06-01
4
A
false
25000
0
A
2020-06-01
2029-06-01
Aptevo Therapeutics Inc. common stock
25000
25000
D
The stock option was granted on June 1, 2019 and becomes exercisable in three equal annual installments beginning on June 1, 2020.
/s/ Niederhuber, John
2019-06-04